PFN1 Gene Polymorphisms and the Bone Mineral Density Response to Alendronate Therapy in Postmenopausal Chinese Women with Low Bone Mass
Jiao Zhao,* Li Liu,* Shanshan Lv, Chun Wang, Hua Yue, Zhenlin Zhang Shanghai Clinical Research Center of Bone Disease, Department of Osteoporosis and Bone Disease, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China*These auth...
Main Authors: | Zhao J, Liu L, Lv S, Wang C, Yue H, Zhang Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-12-01
|
Series: | Pharmacogenomics and Personalized Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/pfn1-gene-polymorphisms-and-the-bone-mineral-density-response-to-alend-peer-reviewed-fulltext-article-PGPM |
Similar Items
-
Association Between CTSK Gene Polymorphisms and Response to Alendronate Treatment in Postmenopausal Chinese Women with Low Bone Mineral Density
by: Yuan H, et al.
Published: (2023-10-01) -
The Impact of Alendronate on Bone Mineral Density of Osteoporotic Patients
by: Hamidreza Aghaei-Meybodi, et al.
Published: (2013-12-01) -
Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis
by: Fatemeh Khanizadeh, et al. -
The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis
by: S. Akı, et al.
Published: (2002-03-01) -
Influence of the Osteogenomic Profile in Response to Alendronate Therapy in Postmenopausal Women with Osteoporosis: A Retrospective Cohort Study
by: Alejandra Villagómez Vega, et al.
Published: (2023-02-01)